Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.4 USD | +3.03% | +12.08% | +46.90% |
05-03 | Oppenheimer Adjusts Kymera Therapeutics Price Target to $52 From $53 | MT |
05-02 | Kymera Therapeutics Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.